Nanotechnology in Medical Devices Market: By Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research)
Global Nanotechnology in Medical Devices Market is valued at USD 863.17 Million in 2022 and is projected to attain a value of USD 2152.49 Million by 2030 at a CAGR of 12.10% during the forecast period.
Nanotechnology in Medical Devices Market Size, 2022 To 2030 (USD Million)
Nanotechnology is an emerging technology that holds great promise for novel medical devices. Nanotechnology promises to revolutionize medicine, particularly in the field of drug delivery, diagnostics, tissue engineering, imaging, and therapeutics. This promise of these devices is based on the ability of nanomaterials to change or enhance material properties on a scale not achievable with conventional materials. For example, nanoparticles are able to be imaged using fluoroscopy that would otherwise require x-rays given their tiny size. Nanoparticle delivery systems have been shown to improve drug delivery across cell membranes which can lead to better targeting of disease for diagnosis and treatment. Nanotechnology applications are rapidly emerging in the field of diagnostic imaging.
Growing Use of Nanoparticle in Drug Delivery
Report Coverage & Deliverables
- Real-Time Data Updates:
- Competitor Benchmarking
- Market Trends Heatmap
- Custom Research Queries
- Market Sentiment Analysis
- Demographic and Geographic Insights
Nanotechnology in medicine offers a great deal of benefits to both patients and medical professionals. Traditional cancer therapies have been found to have negative side effects such as nausea, vomiting and diarrhea so there is a need for better alternatives. As mentioned earlier, nanoparticles have been used successfully to treat cancer by attacking tumor cells only because they are able to penetrate through cell membranes. This means that healthy cells are left unharmed allowing the body to recover much faster. Nanotechnology in Medical Devices will not only prevent and treat cancer but it will also be useful for other applications such as diagnostic techniques, drug delivery system and even regenerative medicine which allows damaged tissues to heal etc.
Lack of Skilled Professionals May Hinder Market Growth
The potential of nanotechnology in medicine has roused interests from many parties such as governments, academic researchers, pharmaceutical companies and even big corporations since it is expected that nanomaterials will play a vital role in various industries such as healthcare and energy etc. However, one of the main concerns that hospitals and research centers face today is the lack of nanotechnology experts. Since this technology field is relatively new, there are very few professionals to take care of current needs let alone future demands for medical applications. This problem has been solved thanks to online nanotechnology courses or nanotechnology degrees which allow students to study at home without having them quit their current jobs.
Nanotechnology in Medical Devices market is segmented into product and application. Based on product market is segmented into biochip, implant materials, medical textiles, wound dressing, cardiac rhythm management devices, and hearing aid. Based on application market is segmented into therapeutic, diagnostic, research.
Below tree is interactive. You can click the nodes to get more information.
Biochip are Expected to Hold Prominence over Nanotechnology in Medical Devices Market
Nanotechnology is at the forefront of biochips. The potentiality and functionality of nano-biochip can be seen in many aspects, such as: microscopy and visualization, cell sorting and drug delivery system. Nano-biochips enable to perform tests with higher accuracy and precision than traditional tests due their nanoscale design which provide high surface area per volume that allows great number of interactions or reactions to take place. Moreover, nanoscale devices can be made to fit into the human body and even cross the blood-brain barrier.
Nanoplatforms provide high specificity and sensitivity for rapid analysis of complex biological samples, especially the increasing importance of biochip is based on increasing gene expression research due to their capacity in delivering therapeutics inside cells through receptors recognition. Researchers are applying nanotechnology to exploit the possibility of using multiplex real time PCR or fluorescent tagging that allows discrimination between different mRNA transcripts.
North America to Dominate Nanotechnology in Medical Devices Market
One reason to this development is the fact that many US companies have been working with DNA technology for a long time already, which makes them better prepared for using nanotechnology to create medical innovations. In addition, south-east USA offers an environment where scientists can work together in various fields such as science, business and law which brings about even further developments in life sciences. In terms of regulations, North America is also much more advanced than Europe. For example, the FDA already has a lot of experience in regulating medical implants and genetic medicine. There is greater standardization in Europe but it still takes twice as long to get through the necessary approvals for an implant or device compared with the US. Moreover, Europe's 'free movement of goods' regulations create problems with the approval of new devices. For example, if an implant is approved in France, it can be used across Europe without further approvals - but only the country where the implant was initially approved has to bear the costs for these repeated registrations.
Some of the key players in the global Nanotechnology in Medical Devices market are 3M Company (U.S.), Stryker Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Affymetrix, Inc. (U.S.), Smith & Nephew, Inc. (U.K.), and PerkinElmer, Inc. (U.S.).
The Nanotechnology in Medical Devices is Segmented as Follows:
- Implant Materials
- Medical Textiles
- Wound Dressing
- Cardiac Rhythm Management Devices
- Hearing Aid
- North America
- Asia Pacific
- Middle East & Africa
- Latin America
|Regions & Countries Covered
- North America - (U.S., Canada, Mexico)
- Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
- Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
- Latin America - (Brazil, Argentina, Rest Of Latin America)
- Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
- 3M Company (U.S.)
- Stryker Corporation (U.S.)
- St. Jude Medical Inc. (U.S.)
- Affymetrix Inc. (U.S.)
- Smith & Nephew Inc. (U.K.)
- and PerkinElmer Inc. (U.S.)
|Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Pricing and purchase options
|Avail of customized purchase options to meet your exact research needs. Explore purchase options